News

Allecra Therapeutics and ADVANZ PHARMA Sign Exclusive License and Supply Agreement for Allecra’s Antibiotic Cefepime/enmetazobactam in Europe

Learn more

ne

Learn more

Press Releases —

ADVANZ PHARMA makes key changes to senior leadership to further accelerate next phase of growth

Learn more

Press Releases —

ADVANZ PHARMA announces launch of MYRELEZ® in Norway, the first generic lanreotide for the treatment of acromegaly and gastroenteropancreatic neuroendocrine tumours (GEP-NETs)

Learn more

ADVANZ PHARMA announces launch of MYTOLAC® in Germany, the first generic lanreotide for the treatment of acromegaly and gastroenteropancreatic neuroendocrine tumours (GEP-NETs)

Learn more